Article
Serine 421 regulates mutant huntingtin toxicity and clearance in mice.
The Journal of clinical investigation - 1 Sept 2016
Kratter Ian H, Zahed Hengameh, Lau Alice, Tsvetkov Andrey S, Daub Aaron C, Weiberth Kurt F, Gu Xiaofeng, Saudou Frédéric, Humbert Sandrine, Yang X William, Osmand Alex, Steffan Joan S, Masliah Eliezer, Finkbeiner Steven
Abstract excerpt
Huntington's disease (HD) is a progressive, adult-onset neurodegenerative disease caused by a polyglutamine (polyQ) expansion in the N-terminal region of the protein huntingtin (HTT). There are no cures or disease-modifying therapies for HD. HTT has a highly conserved Akt phosphorylation site at serine 421, and prior work in HD models found that phosphorylation at S421 (S421-P) diminishes the toxicity of mutant...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
